Lv2
168 积分 2022-05-16 加入
Electron-density informed effective and reliable de novo molecular design and lead optimization with ED2Mol
3天前
已完结
Product Subclass 2: Ortho Esters and Halogenated Derivatives
12天前
已完结
FGFR rearrangements: oncogenic drivers and therapeutic targets
2个月前
已关闭
Brain Penetrant NLRP3 Inhibitors: The Discovery of a Panacea?
3个月前
已完结
Negative Allosteric Modulators of A2AR: A New Weapon for Cancer Immunotherapy?
3个月前
已完结
Turning Off STAT6 with a Targeted Degrader
3个月前
已完结
MDM2 Degrader as a Promising Therapeutic Strategy for Cancer Treatment
3个月前
已完结
CBP/p300 Degrader: A Promising Therapeutic Strategy for Treatment of Prostate Cancer and Beyond
3个月前
已完结
Nasal delivery of secretory IgA confers enhanced neutralizing activity against Omicron variants compared to its IgG counterpart
3个月前
已完结
Lck is a key target of imatinib and dasatinib in T-cell activation
3个月前
已完结
皖公网安备34019202002308
